Immune tolerance in two high responder, severe hemophilia A patients with inhibitors: the importance of high doses and the duration of the treatment.
Ciavarella
N
N
Centro Emofilia, Università Policlinico, Bari, Italia.
Schiavoni
M
M
Fasano
A
A
Giliberti
M G
MG
Ettorre
C
C
Stefanile
C
C
D000293:Adolescent; D005169:Factor VIII / Q000008:administration & dosage* / Q000276:immunology; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D008297:Male
D005169:Factor VIII